In addition, YM155 enhances TRAIL-induced apoptosis through down-regulation of Mcl-1 in TRAIL-resistant glioma cells [25], and p38 MAPK-and CHOP-mediated DR5 up-regulation in breast cancer [26], respectively. This evidence concerns the gene TNFSF10 and breast carcinoma.